{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:59:02Z","timestamp":1785308342781,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.bpg.2020.101688","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T17:51:11Z","timestamp":1600883471000},"page":"101688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["De novo and recurrent liver disease"],"prefix":"10.1016","volume":"46-47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1003-7240","authenticated-orcid":false,"given":"Stephen","family":"Ip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahima A.","family":"Bhanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ebadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo J.","family":"Montano-Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bpg.2020.101688_bib1","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cgh.2017.11.045","article-title":"Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2020.101688_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.02.009","article-title":"Epidemiology and natural history of NAFLD and NASH","volume":"11","author":"Ong","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.bpg.2020.101688_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lt.22004","article-title":"Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease","volume":"16","author":"Yalamanchili","year":"2010","journal-title":"Liver Transplant"},{"issue":"11","key":"10.1016\/j.bpg.2020.101688_bib5","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1097\/TP.0000000000002916","article-title":"Incidence and risks for nonalcoholic fatty liver disease and steatohepatitis post-liver transplant: systematic review and meta-analysis","volume":"103","author":"Saeed","year":"2019","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.bpg.2020.101688_bib6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/lt.23499","article-title":"Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation","volume":"18","author":"Patil","year":"2012","journal-title":"Liver Transplant"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1432-2277.2012.01576.x","article-title":"Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation","volume":"26","author":"Sprinzl","year":"2013","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/TP.0000000000002485","article-title":"Management of recurrent and de novo NAFLD\/NASH after liver transplantation","volume":"103","author":"Germani","year":"2019","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/lt.25338","article-title":"Predictors of de novo nonalcoholic fatty liver disease after liver transplantation and associated fibrosis","volume":"25","author":"Galvin","year":"2019","journal-title":"Liver Transplant"},{"issue":"12","key":"10.1016\/j.bpg.2020.101688_bib10","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.41162","article-title":"Serial liver stiffness measurements and monitoring of liver-transplanted patients in a real-life clinical practice","volume":"16","author":"Rinaldi","year":"2016","journal-title":"Hepat Mon"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","author":"European Association for Study of Liver","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2020.101688_bib12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/lt.23391","article-title":"Transient elastography identifies liver recipients with nonviral graft disease after transplantation: a guide for liver biopsy","volume":"18","author":"Rigamonti","year":"2002","journal-title":"Liver Transplant"},{"issue":"9","key":"10.1016\/j.bpg.2020.101688_bib13","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/lt.25303","article-title":"Liver transplantation and bariatric surgery: timing and outcomes","volume":"24","author":"Diwan","year":"2018","journal-title":"Liver Transplant"},{"issue":"10","key":"10.1016\/j.bpg.2020.101688_bib14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cgh.2011.07.007","article-title":"Increased perioperative mortality following bariatric surgery among patients with cirrhosis","volume":"9","author":"Mosko","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.bpg.2020.101688_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.bpg.2020.101688_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/hep.29848","article-title":"Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy","volume":"68","author":"Zamora-Valdes","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib17","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/TP.0000000000002317","article-title":"Recurrent or de novo allograft steatosis and long-term outcomes after liver transplantation","volume":"103","author":"Narayanan","year":"2019","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.bpg.2020.101688_bib18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/MEG.0000000000001105","article-title":"De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients","volume":"30","author":"Gitto","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/lt.25375","article-title":"Recurrent and de novo autoimmune hepatitis","volume":"25","author":"Stirnimann","year":"2019","journal-title":"Liver Transplant"},{"issue":"2","key":"10.1016\/j.bpg.2020.101688_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1089-3261(05)70167-7","article-title":"Autoimmune liver disease. Current standards, future directions","volume":"5","author":"Gish","year":"2001","journal-title":"Clin Liver Dis"},{"issue":"10","key":"10.1016\/j.bpg.2020.101688_bib21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","author":"Montano-Loza","year":"2009","journal-title":"Liver Transplant"},{"issue":"4","key":"10.1016\/j.bpg.2020.101688_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","author":"Gonzalez-Koch","year":"2001","journal-title":"Liver Transplant"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00007890-200301150-00024","article-title":"Impact of human leukocyte antigen matching in liver transplantation","volume":"75","author":"Neumann","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2020.101688_bib24","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","author":"Mack","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bpg.2020.101688_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/jlts.2001.23085","article-title":"Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome","volume":"7","author":"Hubscher","year":"2001","journal-title":"Liver Transplant"},{"issue":"12","key":"10.1016\/j.bpg.2020.101688_bib26","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.bpg.2020.101688_bib27","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.transproceed.2007.02.030","article-title":"Liver transplantation for autoimmune hepatitis: a single-center experience","volume":"39","author":"Khalaf","year":"2007","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.bpg.2020.101688_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cgh.2011.10.028","article-title":"Autoimmune hepatitis after liver transplantation","volume":"10","author":"Liberal","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2020.101688_bib29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats post-transplant autoimmune hepatitis","volume":"5","author":"Kerkar","year":"2005","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"Krishnamoorthy","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.bpg.2020.101688_bib31","first-page":"856a","article-title":"Factors associated with recurrence of autoimmune hepatitis after liver transplantation and effects on graft and patient survival","volume":"70","author":"Montano-Loza","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bpg.2020.101688_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"issue":"4 Pt 1","key":"10.1016\/j.bpg.2020.101688_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"issue":"9100","key":"10.1016\/j.bpg.2020.101688_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.bpg.2020.101688_bib35","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1478-3231.2012.02832.x","article-title":"Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.bpg.2020.101688_bib36","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"Comprehensive update of the banff working group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.bpg.2020.101688_bib37","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation","volume":"71","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.bpg.2020.101688_bib38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/lt.21447","article-title":"Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus","volume":"14","author":"Fiel","year":"2008","journal-title":"Liver Transplant"},{"issue":"2","key":"10.1016\/j.bpg.2020.101688_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2020.101688_bib40","article-title":"Definition and management of patients with primary biliary cholangitis and an incomplete response to therapy","author":"Montano-Loza","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2020.101688_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/hep4.1058","article-title":"Recurrence of primary biliary cholangitis after liver transplantation: a Japanese perspective","volume":"1","author":"Montano-Loza","year":"2017","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.bpg.2020.101688_bib42","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.bpg.2020.101688_bib43","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/ajt.12132","article-title":"Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Carbone","year":"2013","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.bpg.2020.101688_bib44","first-page":"30","article-title":"Recurrent primary biliary cirrhosis after liver transplantation--the disease and its management","volume":"8","author":"Schreibman","year":"2006","journal-title":"Med Gen Med"},{"issue":"9","key":"10.1016\/j.bpg.2020.101688_bib45","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.bpg.2020.101688_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","author":"Corpechot","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2020.101688_bib48","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"American Association for the Study of Liver D: diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2020.101688_bib49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2013.03.015","article-title":"Update on primary sclerosing cholangitis","volume":"59","author":"Karlsen","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.bpg.2020.101688_bib50","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/lt.24703","article-title":"Outcomes of liver retransplantation in patients with primary sclerosing cholangitis","volume":"23","author":"Henson","year":"2017","journal-title":"Liver Transplant"},{"issue":"2","key":"10.1016\/j.bpg.2020.101688_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transplant"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/PAS.0b013e3181c6c09a","article-title":"IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis","volume":"34","author":"Zhang","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.bpg.2020.101688_bib53","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/TP.0b013e3182845f6c","article-title":"Late acute liver allograft rejection; a study of its natural history and graft survival in the current era","volume":"95","author":"Thurairajah","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.bpg.2020.101688_bib54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transplant"},{"issue":"5","key":"10.1016\/j.bpg.2020.101688_bib55","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2020.101688_bib56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A\u00a0re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transplant"},{"issue":"10","key":"10.1016\/j.bpg.2020.101688_bib57","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"issue":"9349","key":"10.1016\/j.bpg.2020.101688_bib58","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bpg.2020.101688_bib59","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.humpath.2003.07.015","article-title":"Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study","volume":"34","author":"Khettry","year":"2003","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.bpg.2020.101688_bib60","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10620-009-0773-9","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience","volume":"54","author":"Egawa","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"Suppl 3","key":"10.1016\/j.bpg.2020.101688_bib61","first-page":"S463","article-title":"Histological recurrence of autoimmune liver diseases after living-donor liver transplantation","volume":"37","author":"Haga","year":"2007","journal-title":"Hepatol Res"},{"issue":"6","key":"10.1016\/j.bpg.2020.101688_bib62","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.bpg.2020.101688_bib63","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bpg.2020.101688_bib64","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2020.101688_bib65","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2020.101688_bib66","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2018.05.034","article-title":"No superiority of stents vs balloon dilatation for dominant strictures in patients with primary sclerosing cholangitis","volume":"155","author":"Ponsioen","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2020.101688_bib67","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/liv.12027","article-title":"Liver transplantation for overlap syndromes of autoimmune liver diseases","volume":"33","author":"Bhanji","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2020.101688_bib68","first-page":"S373","article-title":"De novo primary sclerosing cholangitis (PSC) post liver transplantation for alcoholic cirrhosis: presidential poster: 1266","volume":"109","author":"Kumar","year":"2014","journal-title":"Off J Am Coll Gastroenterol ACG"},{"issue":"5","key":"10.1016\/j.bpg.2020.101688_bib69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/jlts.2001.23792","article-title":"Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation","volume":"7","author":"Tan","year":"2001","journal-title":"Liver Transplant"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691820300238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691820300238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:01:49Z","timestamp":1761498109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691820300238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":69,"alternative-id":["S1521691820300238"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2020.101688","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De novo and recurrent liver disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2020.101688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101688"}}